Synchron Inc.

08/06/2026

Huge thanks to Jane Simpson, host of Let's Talk MND, for a candid conversation with our CEO Tom Oxley about Synchron's origins, our current clinical trial, and the future of brain-computer interfaces.

Watch the full episode below or listen on Spotify 🎧

https://www.youtube.com/watch?v=4OG3wupRsA0

07/28/2026

Ready for a deep dive into technology? Tune into the latest Fight MND Scientific Seminar for a deep history of BCI research and for a look at what it's like to participate in one of our trials:

Synchron Brain Computer Interface: From Research to Clinical Adopti...

06/25/2026

The trial is designed to explore how Synchron’s minimally invasive BCI may help restore connection and autonomy for people living with .

Register: http://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37&fbclid=IwY2xjawSqLhtleHRuA2FlbQIxMABicmlkETFlSUNPNGxWRW5uTnJPbzR4c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHp3hLpZvh56Qe5I4ZDNDxCeLxpfI76k0e3-XVHW98MPztFXMgj4KQ1yaNII0_aem_TRx3NjevTnwYAvYRVLPOAg

06/25/2026

Could brain-computer interface technology help transform the lives of people living with paralysis and MND?

Join experts from Synchron as they explore how brain-computer interfaces (BCIs) are moving from research into real-world clinical use, the importance of measuring meaningful patient outcomes, and insights from the FOCUS-AUS trial, Synchron's second Australian clinical trial.

Hear from:
• Dr Omid Forouzan, Vice President, Clinical and Medical Affairs at Synchron
• Dr Adam Fry, Clinical Science Manager at Synchron

This seminar will provide a fascinating look at the future of BCI technology and the work being done to bring these innovations to the people who need them most.

Register via the link: https://bit.ly/4xpliei

05/26/2026

Caregivers play an essential role in clinical trials. If your loved one is living with , encourage them to speak with their doctor about the . Together, we’re building new possibilities for care and independence. ��

🔗 Learn more and register your loved one here: https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/20/2026

🚨 Enrollment NOW OPEN at select U.S. sites! INTENT trial: evaluating BCI safety + independence in .

📌 Register ➡️ https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/18/2026

What is the INTENT trial?

✅ INTENT stands for INdependence Through Endovascular Neuroprosthetic Technology
✅ FDA-approved clinical trial
✅ Evaluating safety of Synchron’s brain-computer interface (BCI)
✅ Exploring how BCI may improve communication and independence

🔗 Learn more and register: https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/18/2026

Don't miss our upcoming webinar with MND Australia! We'll share insights on what a BCI is, how it works, and how it's being developed for people living with motor neurone disease.

Join MND Australia and Synchron for a webinar exploring Synchron’s Brain-Computer Interface (BCI) technology – what it is, how it works, and how it's being developed for people living with motor neurone disease.

Date: Wednesday, 3 June 2026
Time: 12pm AEST
Register: https://bci-webinar.researchstudytrialau.com/

Brain-Computer Interface (BCI) is a small, implanted medical device designed to help people control digital devices using only their thoughts, without the need for eye tracking, voice commands, or hand movements.

In April 2026, Synchron launched the next phase of their FOCUS-AUS Study in Australia, designed to continue to evaluate safety while also exploring how Synchron’s BCI may improve quality of life for people with motor impairments.

The webinar will include insights from past research participants and outcomes from Synchron’s prior clinical trials.

Registrants will have the opportunity to join the Synchron BCI Community, and stay up-to-date on current happenings and clinical trial opportunities.

Register for the webinar: https://bci-webinar.researchstudytrialau.com/

05/06/2026

We’ve opened enrollment for our Australian clinical trial evaluating Synchron’s minimally invasive brain-computer interface.

The study will take place across sites in Melbourne and Sydney, supporting people living with motor neuron disease (MND). The goal of this study is to assess whether participants can control digital devices with their thoughts—enabling everyday actions like sending messages, browsing the internet, and operating smart home technologies.

This marks an important step forward in the broader clinical evaluation of brain-computer interface technology.

Our goal is to restore independence and communication for patients living with severe paralysis, without the need for open brain surgery.

Australia is a key part of our global clinical strategy, and we’re proud to advance this work in the country where Synchron was founded.

The FOCUS-AUS patient registry is now live: https://synchronbci.com/

Watch this video interview between Nine and Rodney, an individual living with the Stentrode™ BCI implant:

The Synchron BCI is for clinical investigation use only.

04/28/2026

Incredible to see Synchron recognized by TIME on its inaugural Companies Industry Leaders list.

At Synchron, we’re advancing brain-computer interface technology to restore independence for people with paralysis, enabling connection and control through thought.

Congrats to the team, our partners, users and their families on this well-deserved recognition!

Read the article: https://time.com/article/2026/04/27/time100-companies-new-frontiers/

Learn more about our studies: https://synchronbci.com/